ELEANOR DIONISE: Open Payments
NPI 1073246732 · GRAND LEDGE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,970 in 152 payments from 20 companies in 2025. Trend: 2023 $1,846 · 2024 $1,755 · 2025 $2,970
Food & beverage: $2,832Education: $138
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $573 |
| Janssen Biotech, Inc. | 45 | $562 |
| Amgen Inc. | 23 | $415 |
| AstraZeneca Pharmaceuticals LP | 12 | $384 |
| UCB, Inc. | 14 | $312 |
| Janssen Scientific Affairs, LLC | 1 | $108 |
| GENZYME CORPORATION | 1 | $106 |
| Alexion Pharmaceuticals, Inc. | 1 | $94 |
| Fresenius Kabi USA, LLC | 3 | $71 |
| Radius Health, Inc. | 2 | $47 |
Products named: TREMFYA, RINVOQ, Bimzelx, SAPHNELO, EVENITY, ENBREL, KEVZARA, Tymlos.
Industry payments across MI — which companies pay providers there.
